top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

1 min read

Dr. David Battleman Appointed President & CEO of BioFuse Medical Technologies, Leading Advancements in Surgical Innovation

Melbourne, FL, March 26, 2024 (Accesswire) -- BioFuse Medical Technologies appoints David Battleman, MD, MBA, MSc, as President & CEO to advance healthcare through innovative surgical solutions. Dr. Battleman will lead the development and launch of BioFuse's RF surgical welding devices, leveraging his wealth of experience and expertise.

Read full article here.

Recent Posts

Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Santa Cruz, CA, December 13, 2024 (Yahoo) -- Capstan Medical has raised $110 million in a Series C funding round led by Eclipse, with...

Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

Philadelphia, December 4, 2024 (PRNewswire) -- Dr. Vatsala Naageshwaran, an accomplished biopharmaceutical leader, has been appointed...

SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments

South San Francisco, CA, December 18, 2024 (Business Wire) -- SiteOne Therapeutics has raised $100 million in Series C funding to...

Comentarios

Life Science Headlines

Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments

Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth

AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform

Coherus Divests UDENYCA Franchise to Intas in $558.4M Deal to Fund Immuno-Oncology Expansion

COUR Pharmaceuticals Secures $40M Upfront in Genentech Deal, Potential Milestones Exceed $900M

BioFuse Medical Technologies Appoints Rick Early as CEO

Velentium Appoints Matt Hanks as CEO, Co-Founder Dan Purvis Named Board Chair to Propel Growth

Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough

bottom of page